TPF plus cetuximab (E) induction chemotherapy (ICT) followed by biochemoradiation (BCRT) with weekly E plus weekly cisplatin (P) or carboplatin (C) in stage III/IV squamous cell carcinoma of the head and neck (HNSCC): A randomized phase II EORTC trial.

Pol Specenier, Jan B. Vermorken, Jan Buter et al.|Journal of Clinical Oncology|2016

Cited by 1